MorphoSys stock tumbles 24% post-market amid Phase 3 data (update)
Post Content
Similar Posts
Economists predict BOJ to end negative rates by next year
Post Content Post Views: 127
Analysis-Appetite for stocks drives VIX options as investors guard portfolios
Post Content Post Views: 113
China preparing list of 50 property developers that can get funding – report
Post Content Post Views: 136
Berkshire Hathaway Class A shares yield over 4,400,000% return since Buffett takeover
Post Content Post Views: 103
Keysight Q4 2023 Earnings Preview
Post Content Post Views: 146
Bad news for Black Friday: Retailers cast doubt on holiday shopping with cautious guidance
Retailers have been cautious headed into the holidays, spelling trouble for the crucial shopping season and raising questions about the health of the economy. Post Views: 105